Jefferson University Hospitals

Provider Profile

James F. Vander, MD

James F. Vander, MD

Academic Title: Clinical Professor

Specialties
Ophthalmology - Retina

Make An Appointment

Click to call 1-800-JEFF-NOW (800-533-3669) or

Office Locations

Plymouth Meeting
4060 Butler Pike
Suite 200
Plymouth Meeting PA 19462
Phone: (800) 331-6634
Philadelphia
840 Walnut Street
Suite 1020
Philadelphia PA 19107
Phone: (800) 331-6634

Medical Services

Years in Practice

28

Board Certifications

  • OPH Retina
  • Ophthalmology

Hospital Affiliation / Admitting Privileges

  • Thomas Jefferson University Hospital

Awards and Honors

Philadelphia Magazine's Top Docs 2016,2015,2014,2012,2011,2010

Education

  • University of Michigan Medical School, Medical School

Internship

  • University of Michigan Hospital

Residency

  • University of Michigan Hospital

Fellowship

  • Wills Eye Hospital

Jefferson physicians accept most health insurance plans, including those listed below. However, plan acceptance may vary by practice and may be subject to change. If you have questions about whether a specific physician accepts your insurance, please contact your insurance company.

Insurances Accepted

  • Aetna
  • Blue Cross/Blue Shield
  • Commercial
  • CorVel
  • Geisinger Health Plan
  • Horizon Blue Cross/Blue Shield
  • HumanaChoicePPO,Medicare,GoldPlusHMO
  • Keystone Health Plan East
  • Medicaid of PA
  • Medicare
  • Personal Choice (GPPPN)
  • Personal Choice 65
  • Tricare
  • Workers Comp

Recent Publications

Alternating Bi-Weekly Intravitreal Ranibizumab and Bevacizumab for Refractory Neovascular Age-Related Macular Degeneration with Pigment Epithelial Detachment*

A RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROL PILOT STUDY OF EPLERENONE FOR THE TREATMENT OF CENTRAL SEROUS CHORIORETINOPATHY (ECSELSIOR)

Re: Effect of Aflibercept on Refractory Macular Edema Associated with Central Retinal Vein Occlusion

Effect of aflibercept on refractory macular edema associated with central retinal vein occlusion

Topical dorzolamide-timolol with intravitreous anti-vascular endothelial growth factor for neovascular age-related macular degeneration

The effect of prophylactic topical antibiotics on bacterial resistance patterns in endophthalmitis following intravitreal injection

Microbial spectrum and outcomes of endophthalmitis after intravitreal injection versus pars plana vitrectomy

Effect of a strict 'no-talking' policy during intravitreal injection on post-injection endophthalmitis

Subretinal Hyperreflective Material in the Comparison of Age-Related Macular Degeneration Treatments Trials

En Face Optical Coherence Tomography of Subfoveal Perfluorocarbon Liquid

Spectral-Domain Optical Coherence Tomography in Acute Posterior Vitreous Detachment

Oral eplerenone for treatment of chronic central serous chorioretinopathy: A case series

Baseline choroidal thickness as a predictor for response to anti-vascular endothelial growth factor therapy in diabetic macular edema

Retinal injury after inadvertent handheld laser exposure

I see a seashell in my right eye

Intravitreal triamcinolone acetonide injection for macular edema due to central retinal vein occlusion persisting despite multiple intravitreal bevacizumab injections

Conjunctival flora antibiotic resistance patterns after serial intravitreal injections without postinjection topical antibiotics

The role of topical antibiotic prophylaxis to prevent endophthalmitis after intravitreal injection

Pars plana vitrectomy and scleral buckle versus pars plana vitrectomy alone for patients with rhegmatogenous retinal detachment at high risk for proliferative vitreoretinopathy

Diseases of the retina and vitreous